The relatively high level of expression of caspase-8 in lenalidomide-resistant RPMI-8226 cells suggested that the expression of caspase-8 might affect lenalidomide sensitivity in myeloma cells (Figure 2A); however, this hypothesis has not been investigated yet. This evidence concerns the gene CASP8 and plasma cell myeloma.